Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism1-Reference-Cited by-同舟云学术

Donor lymphocyte infusion-mediated graft-versus-leukemia effects in mixed chimeras established with a nonmyeloablative conditioning regimen: extinction of graft-versus-leukemia effects after conversion to full donor chimerism1

Published:2003-07-27 Issue:2 Volume:76 Page:297-305
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Mapara Markus Y.,Kim Yong-Mi,Marx Julie,Sykes Megan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference23 articles.

1. Lymphohematopoietic graft-vs-host reactions can be induced without graft-vs-host disease in murine mixed chimeras established with a cyclophosphamide-based non-myeloablative conditioning regimen;Pelot;Biol Blood Marrow Transplant,1999

2. Graft-versus-host-related immunosuppression is induced in mixed chimeras by alloresponses against either host or donor lymphohematopoietic cells;Sykes;J Exp Med,1988

3. Donor Lymphocyte infusions (DLI) mediate superior graft-versus-leukemia (GvL) effects in mixed compared to fully allogeneic chimeras: A critical role for host antigen-presenting cells;Mapara;Blood,2002

4. Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen;Sharabi;J Exp Med,1989

5. Mixed chimerism and tolerance without whole body irradiation in a large animal model;Fuchimoto;J Clin Invest,2000

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tolerance in intestinal transplantation;Human Immunology;2024-05

2. Immunopathogenic mechanisms and modulatory approaches to graft-versus-host disease prevention in acute myeloid leukaemia;Best Practice & Research Clinical Haematology;2023-06

3. Immunotherapy for neuroblastoma by hematopoietic cell transplantation and post-transplant immunomodulation;Critical Reviews in Oncology/Hematology;2023-05

4. Leveraging the lymphohematopoietic graft-versus-host reaction (LGVHR) to achieve allograft tolerance and restore self tolerance with minimal toxicity;Immunotherapy Advances;2023-01-01

5. Retention of Donor T Cells in Lymphohematopoietic Tissue and Augmentation of Tissue PD-L1 Protection for Prevention of GVHD While Preserving GVL Activity;Frontiers in Immunology;2022-05-23